Products

PRODUCT CENTER
Your present position:
Home >
API
甲磺酸萘莫司他

甲磺酸萘莫司他

Nafamostat is a synthetic serine protease inhibitor that is commonly formulated with hydrochloric acid due to its basic properties. It has been used in trials studying the prevention of Liver Transplantation and Postreperfusion Syndrome. The use of nafamostat in Asian countries is approved as an anticoagulant therapy for patients undergoing continuous renal replacement therapy due to acute kidney injury.
Packing specification:
Dosage form
API

Product details

The product name 甲磺酸萘莫司他 Report progress Prepare to register
English names Nafamostat Mesylate indications Used as an anticoagulant in patients with disseminative blood vessel coagulation, hemorrhagic lesions, and hemorrhagic tendencies.
CAS no. 82956-11-4 place of origin
IDL no./Registration no. Dosage form API
Chemical name (6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate;methanesulfonic acid

return